Telemetry Investments LLC has recently announced that it has increased stake in Fresh Tracks Therapeutics Inc. (NASDAQ:FRTX) by 173.73%. After grabbing 66000.0 shares, the institutional investor is now in possession of 41889.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 2.19% having worth around $0.13 million. Moreover, Thrivent Trust Co. increased its share by 39876.0 to have a control over 41243.0 shares. And Millennium Management LLC raised its holdings to 17603.0 shares by acquiring 28730.0 shares or 0.95% of the stake.
Fresh Tracks Therapeutics Inc. (FRTX) concluded trading on 01/11/23 at a closing price of $1.84, with 1.36 million shares of worth about $2.49 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -45.88% during that period and on Wednesday the price saw a gain of about 7.60%. Currently the company’s common shares owned by public are about 3.01M shares, out of which, 2.98M shares are available for trading.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 1 analysts are covering the FRTX stock and their offered price forecasts bring an average price target of $12.00. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $12.00 and could fall to a lowest price of $12.00. The stock’s current price level is 59.11% above of average price target set by the analysts, while a rise to estimated low would result in gain of 84.67% for the stock. However, touching the estimated high of $12.00 would mean a gain of 84.67% for the stock.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 0 times over the past 12 months. They bought 0 shares in 0 of the transactions. In 0 selling transactions, insiders dumped 0 shares.
Vanguard Extended Market Index Fu, Fidelity Extended Market Index Fu, and SQUAD Point Five are the top 3 mutual funds which are holding stakes in Fresh Tracks Therapeutics Inc. Vanguard Extended Market Index Fu is currently holding 27779.0 shares of worth totaling $52780.0. The company recently came buying 0.0 shares which brought its stake up to 0.92% of the company’s outstanding shares. SQUAD Point Five, after buying 3120.0 shares, have now control over 0.10% of the stake in the company. It holds 2514.0 shares of worth $5928.0.
Fresh Tracks Therapeutics Inc. (NASDAQ: FRTX) started trading at $1.70, below -$0.01 from concluding price of the previous day. However, the stock later moved at a day high price of 2.0000, or with a gain of 7.60%. Stock saw a price change of 13.58% in past 5 days and over the past one month there was a price change of 17.20%. Year-to-date (YTD), FRTX shares are showing a performance of 22.67% which decreased to -81.51% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.30 but also hit the highest price of $18.94 during that period. The average intraday trading volume for Fresh Tracks Therapeutics Inc. shares is 41.58K. The stock is currently trading 22.28% above its 20-day simple moving average (SMA20), while that difference is up 7.36% for SMA50 and it goes to -60.36% lower than SMA200.
Telemetry Investments LLC acquired 66000.0 shares of Fresh Tracks Therapeutics Inc. having value of about $0.13 million. Data submitted at the U.S SEC by Telemetry Investments LLC revealed that the firm now holds 41889.0 shares in the company valued at close to $77075.76, or have control over 173.73% stake in the company. Fresh Tracks Therapeutics Inc. (NASDAQ: FRTX) currently have 3.01M outstanding shares and institutions hold larger chunk of about 11.90% of that. Holding of mutual funds in the company is about 1.50% while other institutional holders and individual stake holders have control over 5.98% and — of the stake respectively.
The stock has a current market capitalization of $5.45M and its 3Y-monthly beta is at 0.30. It has posted earnings per share of -$8.57 in the same period. It has Quick Ratio of 4.40 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for FRTX, volatility over the week remained 9.65% while standing at 10.51% over the month.
Analysts are in expectations that Fresh Tracks Therapeutics Inc. (FRTX) stock would likely to be making an EPS of -$1.89 in the current quarter, while forecast for next quarter EPS is -$0.91 and it is -$5.23 for next year. For the current quarter EPS, analysts have given the company a lowest target -$1.96 which is -$1.82 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$7.2 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 42.40% while it is estimated to increase by 26.70% in next year.
Analysts at 1 brokerage firms have issued recommendations for the Fresh Tracks Therapeutics Inc. (FRTX)’s stock and average of those rates the stock at a “Moderate Buy” and assign it a score of 2.00. Out of those 1 Wall Street analysts, 1 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
